Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab

por Bagegni, Nusayba A, Davis, Andrew A, Clifton, Katherine K, Ademuyiwa, Foluso O
Publicado 2022

Loneliness, social isolation, and social support in older adults with active cancer during the COVID-19 pandemic

por Clifton, Katherine, Gao, Feng, Jabbari, JoAnn, Van Aman, Mary, Dulle, Patricia, Hanson, Janice, Wildes, Tanya M.
Publicado 2022

Characterization of bone only metastasis patients with respect to tumor subtypes

por Parkes, Amanda, Clifton, Katherine, Al-Awadhi, Aydah, Oke, Oluchi, Warneke, Carla L., Litton, Jennifer K., Hortobagyi, Gabriel N.
Publicado 2018

Prognostic Factors in Patients with Metastatic Breast Cancer with Bone‐Only Metastases

por Parkes, Amanda, Warneke, Carla L., Clifton, Katherine, Al‐Awadhi, Aydah, Oke, Oluchi, Pestana, Roberto Carmagnani, Alhalabi, Omar, Litton, Jennifer K., Hortobagyi, Gabriel N.
Publicado 2018

A phase II trial of an alternative schedule of palbociclib and embedded serum TK1 analysis

por Krishnamurthy, Jairam, Luo, Jingqin, Suresh, Rama, Ademuyiwa, Foluso, Rigden, Caron, Rearden, Timothy, Clifton, Katherine, Weilbaecher, Katherine, Frith, Ashley, Roshal, Anna, Tandra, Pavan K., Cherian, Mathew, Summa, Tracy, Haas, Brittney, Thomas, Shana, Hernandez-Aya, Leonel, Bergqvist, Mattias, Peterson, Lindsey, Ma, Cynthia X.
Publicado 2022

Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor...

por Gerratana, Lorenzo, Davis, Andrew A., Velimirovic, Marko, Clifton, Katherine, Hensing, Whitney L., Shah, Ami N., Dai, Charles S., Reduzzi, Carolina, D’Amico, Paolo, Wehbe, Firas, Medford, Arielle, Wander, Seth A., Gradishar, William J., Behdad, Amir, Puglisi, Fabio, Ma, Cynthia X., Bardia, Aditya, Cristofanilli, Massimo
Publicado 2023

A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)

por Ademuyiwa, Foluso O., Northfelt, Donald W., O’Connor, Tracey, Levine, Ellis, Luo, Jingqin, Tao, Yu, Hoog, Jeremy, Laury, Marie L., Summa, Tracy, Hammerschmidt, Trish, Guo, Zhanfang, Frith, Ashley, Weilbaecher, Katherine, Opyrchal, Mateusz, Aft, Rebecca, Clifton, Katherine, Suresh, Rama, Bagegni, Nusayba, Hagemann, Ian S., Iglesia, Michael D., Ma, Cynthia X.
Publicado 2023

Identification of Actionable Fusions as an Anti-EGFR Resistance Mechanism Using a Circulating Tumor DNA Assay

por Clifton, Katherine, Rich, Thereasa A., Parseghian, Christine, Raymond, Victoria M., Dasari, Arvind, Pereira, Allan Andresson Lima, Willis, Jason, Loree, Jonathan M., Bauer, Todd M., Chae, Young Kwang, Sherrill, Gary, Fanta, Paul, Grothey, Axel, Hendifar, Andrew, Henry, David, Mahadevan, Daruka, Nezami, Mohammad Amin, Tan, Benjamin, Wainberg, Zev A., Lanman, Richard, Kopetz, Scott, Morris, Van
Publicado 2019

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer

por Davis, Andrew A., Gerratana, Lorenzo, Clifton, Katherine, Medford, Arielle J., Velimirovic, Marko, Hensing, Whitney L., Bucheit, Leslie, Shah, Ami N., D'Amico, Paolo, Reduzzi, Carolina, Zhang, Qiang, Dai, Charles S., Denault, Elyssa N., Bagegni, Nusayba A., Opyrchal, Mateusz, Ademuyiwa, Foluso O., Bose, Ron, Gradishar, William J., Behdad, Amir, Ma, Cynthia X., Bardia, Aditya, Cristofanilli, Massimo
Publicado 2022

Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor–Positive (HR+)/HER2-Negative Metastatic Breast Cancer

por Davis, Andrew A., Luo, Jingqin, Zheng, Tiantian, Dai, Chao, Dong, Xiaoxi, Tan, Lu, Suresh, Rama, Ademuyiwa, Foluso O., Rigden, Caron, Rearden, Timothy P., Clifton, Katherine, Weilbaecher, Katherine, Frith, Ashley, Tandra, Pavan K., Summa, Tracy, Haas, Brittney, Thomas, Shana, Hernandez-Aya, Leonel F., Peterson, Lindsay L., Wang, Xiaohong, Luo, Shujun J., Zhou, Kemin, Du, Pan, Jia, Shidong, King, Bonnie L., Krishnamurthy, Jairam, Ma, Cynthia X.
Publicado 2023